Loading clinical trials...
Loading clinical trials...
Phase II, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Patients With Moderate to Severe Ulcerative Colitis
Conditions
Interventions
GLPG1205
Placebo
Locations
39
Belgium
St. Pierre University Hospital Center
Brussels, Belgium
Leuven University Hospital
Leuven, Belgium
Clinic Saint-Joseph
Liège, Belgium
Hepato-Gastroenterology HK Ltd.
Hradec Králové, Czechia
Outpatient Clinic of Internal Medicine and Gastroenterology
Pilsen, Czechia
Orlickoustecka Hospital, Inc.
Ústí nad Orlicí, Czechia
Start Date
December 1, 2014
Primary Completion Date
September 1, 2015
Completion Date
November 1, 2015
Last Updated
November 20, 2015
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Galapagos NV
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions